Patent · US Active

Treatment of inflammatory lesions of rosacea with ivermectin

US9233117B2 · kind B2 · utility

11Cited by

13References

19Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Jean JACOVELLA · Antibes, FR
Jean-Paul CHAPPUIS · Valbonne, FR
Nathalie SORDELLO WAGNER · Pégomas, FR
Michael Graeber · Berlin, DE
Alexandre KAOUKHOV · Newport Beach, US
Laurence Salin · Mougins, FR
Michel Poncet · Mougins, FR
Philippe BRIANTAIS · Antibes, FR
Khaled BENKALI · Antibes, FR

Key dates

Filing date	Mar 13, 2014
Grant date	Jan 12, 2016
Priority date	—
Expiry date	Mar 13, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P33/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for safe and effective treatment of inflammatory lesions of rosacea in a subject are described. The methods involve once daily topically applying to an affected skin area a topical composition containing ivermectin and a pharmaceutically acceptable carrier. It has been demonstrated that once daily topical treatment with ivermectin is significantly superior than twice-daily topical treatment with metronidazole in reducing inflammatory lesion counts.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.